Gram-Scale Synthesis of an Arylsulfonamide-Type Alkaline Phosphatase Inhibitor

Area of Science:

• Biochemistry
• Enzymology
• Medicinal Chemistry

Background:

• Alkaline phosphatases (ALP) are metalloenzymes crucial in physiological processes and disease.
• Inhibiting ALP is a therapeutic strategy for certain diseases and for studying enzyme function.
• SBI-425 is a potent ALP inhibitor with a low IC50 value (16 nM).

Purpose of the Study:

• To develop a scalable and efficient synthesis method for the ALP inhibitor SBI-425.
• To prepare larger quantities of SBI-425 for in vivo experiments.
• To confirm the biological activity of synthesized SBI-425.

Main Methods:

• A three-step synthesis starting from 4-chloroanisole.
• Acylation of 3-aminonicotinamide with a sulfonyl chloride intermediate.
• Purification and analysis using Ultra-Performance Liquid Chromatography-Mass Spectrometry (UPLC-MS).

Main Results:

• SBI-425 was synthesized with >90% purity in three steps.
• The synthesis is scalable, with identical outcomes on a 10-fold scale increase.
• The synthesized SBI-425 effectively inhibited alkaline phosphatase activity in mouse serum.

Conclusions:

• A scalable, chromatography-free synthesis of SBI-425 has been established.
• The method provides high-purity SBI-425 suitable for in vivo studies.
• The synthesized SBI-425 demonstrates biological efficacy in inhibiting ALP activity.